Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses (2024)

Historic Other Accumulated Expenses for Zhengye Biotechnology Holding (ZYBT) over the last 1 years, with Q4 2024 value amounting to $20325.5.

  • Zhengye Biotechnology Holding's Other Accumulated Expenses changed N/A to $20325.5 in Q4 2024 from the same period last year, while for Dec 2024 it was $20325.5, marking a year-over-year change of. This contributed to the annual value of $20318.9 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Other Accumulated Expenses of $20325.5 as of Q4 2024.
  • Over the past 5 years, Zhengye Biotechnology Holding's Other Accumulated Expenses peaked at $20325.5 during Q4 2024, and registered a low of $20325.5 during Q4 2024.